Our team of experts will help you navigate through challenges in CMC, external manufacturing alliances, program management, tech ops, supply chain, and regulatory strategy. At Pharmagnosis, we don't just solve challenges; we harness them to propel your company forward. 

Working with early-stage biotechs and universities, the team supports the development of gene and cell therapies, oligonucleotides, biologics, and ADCs across a wide range of therapeutic areas. 

We have expertise in program management and product development, manufacturing operations, regulatory affairs, and strategy, and we provide scientific and technical advice to help a seamless transition from bench side to bedside.

Pharmagnosis was founded by Dr. Resham Banga, an industry expert in drug development, manufacturing, and supply chain operations.  Dr. Banga received his Ph.D. in Chemical and Biological Engineering from Northwestern University, developing non-viral-based therapies for gene delivery. His patented technologies were adopted by a startup to create a variety of treatments. While at Biogen, Dr. Banga spearheaded technology transfers of various biologics and oligonucleotides. He transitioned to Solid Biosciences, where he managed the Manufacturing and Supply Chain operations.